Table of contents

Papers

• Host–pathogen interactions: the seduction of molecular cross talk (1 May, 2002)

  P Sansonetti
• Toxins and the gut: role in human disease (1 May, 2002)

  A Fasano
• Novel targets for the control of secretory diarrhoea (1 May, 2002)

  M J G Farthing
• Helicobacter and gastric MALT lymphoma

  (1 May, 2002)

  M Stolte, E Bayerdörffer, A Morgner, B Alpen, T Wündisch, C Thiede, A Neubauer
• Cyclooxygenase inhibition: between the devil and the deep blue sea (1 May, 2002)

  C J Hawkey
• The genetic jigsaw of inflammatory bowel disease (1 May, 2002)

  D A Watts, J Satsangi
• Influence of treatment on morphological features of mucosal inflammation (1 May, 2002)

  K Geboes, I Dalle
• New steroids and new salicylates in inflammatory bowel disease: a critical appraisal (1 May, 2002)

  M Campieri
• Small therapeutic molecules for the treatment of inflammatory bowel disease (1 May, 2002)

  S J H van Deventer
• Probiotics: a role in the treatment of intestinal infection and inflammation? (1 May, 2002)

  E Isolauri, P V Kirjavainen, S Salminen
• Immunoregulation in the gut: success and failures in human disease (1 May, 2002)

  I Monteleone, P Vavassori, L Biancone, G Monteleone, F Pallone